Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
Alphonse E. Sirica, Gregory J. Gores, John D. Groopman, et al.
Hepatology (2018) Vol. 69, Iss. 4, pp. 1803-1815
Open Access | Times Cited: 273

Showing 1-25 of 273 citing articles:

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1722
Cholangiocarcinoma
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 503
Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription
Qinjunjie Chen, Haibo Wang, Zheng Li, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 1, pp. 135-147
Open Access | Times Cited: 172
M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma
Xinyao Qiu, Shuai Yang, Shan Wang, et al.
Cancer Research (2021) Vol. 81, Iss. 18, pp. 4778-4793
Open Access | Times Cited: 167
Extracellular vesicles as biomarkers in liver diseases: A clinician's point of view
Sara Thietart, Pierre‐Emmanuel Rautou
Journal of Hepatology (2020) Vol. 73, Iss. 6, pp. 1507-1525
Open Access | Times Cited: 148
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
Jianwei Qu, Haimeng Yan, Yifan Hou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 143
SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling
Chong Zeng, Jie Lin, Ketao Zhang, et al.
Cancer Science (2022) Vol. 113, Iss. 11, pp. 3766-3775
Open Access | Times Cited: 79
Tumor‐derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression
Chu‐Bin Luo, Haoyang Xin, Zheng‐Jun Zhou, et al.
Hepatology (2022) Vol. 76, Iss. 4, pp. 982-999
Closed Access | Times Cited: 73
Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD
Yang Long, Kunwei Niu, Jianlin Wang, et al.
Journal of Hepatology (2024)
Open Access | Times Cited: 30
The tumour microenvironment and immune milieu of cholangiocarcinoma
Luca Fabris, María J. Perugorria, Joachim C. Mertens, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 63-78
Open Access | Times Cited: 143
Recent advances of immunotherapy for biliary tract cancer
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology (2020) Vol. 15, Iss. 5, pp. 527-536
Closed Access | Times Cited: 116
Downregulation of Fat Mass and Obesity Associated (FTO) Promotes the Progression of Intrahepatic Cholangiocarcinoma
Zhuoxian Rong, Zhi Li, Junju He, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 108
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
Fei Song, Bo Hu, Jianwen Cheng, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 7
Open Access | Times Cited: 92
Association of gut microbiome and primary liver cancer: A two‐sample Mendelian randomization and case–control study
Jun Ma, Jialiang Li, Jin Chen, et al.
Liver International (2022) Vol. 43, Iss. 1, pp. 221-233
Closed Access | Times Cited: 63
Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma
Youpei Lin, Lihua Peng, Liangqing Dong, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2350-2371
Open Access | Times Cited: 50
miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5
Jingbang Wu, Beng Yang, Yanpeng Zhang, et al.
International Journal of Biological Sciences (2019) Vol. 15, Iss. 8, pp. 1591-1599
Open Access | Times Cited: 63
Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer
Eleanna Kaffe, Christiana Magkrioti, Vassilis Aidinis
Cancers (2019) Vol. 11, Iss. 11, pp. 1626-1626
Open Access | Times Cited: 63
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors
Jia‐Cheng Lu, Haiying Zeng, Qi‐Man Sun, et al.
Theranostics (2019) Vol. 9, Iss. 16, pp. 4678-4687
Open Access | Times Cited: 62
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis
Serena Mancarella, Grazia Serino, Francesco Dituri, et al.
Cell Death and Differentiation (2020) Vol. 27, Iss. 8, pp. 2330-2343
Open Access | Times Cited: 53
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma
Giulia Cristinziano, Manuela Porru, Dante Lamberti, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 351-362
Closed Access | Times Cited: 50
Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell–Mediated Antitumor Activity
Hao Zheng, Wenjuan Zheng, Zhenguang Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Artificial intelligence CT radiomics to predict early recurrence of intrahepatic cholangiocarcinoma: a multicenter study
Yangda Song, Guangyao Zhou, Yucheng Zhou, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 1016-1027
Closed Access | Times Cited: 19
m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/β-catenin signaling pathway
Daimin Xiang, Mingye Gu, Junyu Liu, et al.
Cancer Letters (2023) Vol. 560, pp. 216144-216144
Closed Access | Times Cited: 18
Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma
Yanjie Zhong, Xi-Mei Luo, Fei Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Whole-genome DNA methylation profiling of intrahepatic cholangiocarcinoma reveals prognostic subtypes with distinct biological drivers
Haotian Liao, Xing Chen, Haichuan Wang, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1747-1763
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top